Thanks jonzobot and thanks as well for your last 2 very well thought out, researched and reasoned posts.

I've been looking at companies like Repare Therapeutics, Point Pharmaceutical (which is now going NASDAQ using a SPAC), AbCellara Biologics, Acuitas Therapeutics, Fusion Pharmaceuticals, Aurinia Pharmaceuticals, Bellus Health, Zyme Works, etc and I have not done enough research to draw firm conclusions at the level of rigour you provided, howerever, the broad impressions I get are as follows;

1. The CEO does not always also occupy the Chairman of the Board position.
2. Boards tend to be a bit larger and loaded with biotech, business and finance  talent, (e,g, the CEO of CRISPR is on the board of Repare Therapeutics).
3. There "seems" to be a balance of power across the executive team.
4. Some of these companies are loaded with business strength (biotech, consultancies, MBAs, finance, etc).
5. Some CEO's come from senior positions in BPs and they have deep connections.
6. It seems like these people are doers and highly motivated achievers.

These are just rough observations from reading on their websites and not at well researched.

I guess I just wish Don would seek the help he needs to get this company moving. It is time for this little company to think and act REALLY big...at least as big as apabetlone's potential. Based on the science I'm sure there are extremely capable and highly interested business people that would love to jump in and help out.

I started becomming suspicious and critical of Don back in my Stockhouse posting days when he did not seem to be attracting a solid base of financing(for this breakthrough science) and everything started seeming like a struggle. Now I wonder why the Canadian biotech financing companies like the ones that made Repare happen are not helping RVX. The money and talent seems to exist in Canada although I'm not an expert in this area.

Thanks again jonzobot for stimulating and excellent conversation this past week.

GLTA - good things are going to happen!!!

Toinv